Latest Payments News

CAR Group has reported robust half-year results for FY25, showcasing strong revenue, EBITDA, and profit growth across its global digital automotive marketplaces. The company’s strategic investments and market leadership underpin its optimistic outlook for continued expansion.

CAR Group has reported robust half-year results for FY25, showcasing strong revenue and earnings growth across its global markets, underpinned by strategic diversification and innovation.

CAR Group Limited has announced a semi-annual ordinary dividend of AUD 0.385 per share, partially franked at 50%, payable in April 2025. Shareholders can opt into a Dividend Reinvestment Plan with no discount, reflecting steady shareholder returns.

Ansell Limited has announced a USD 0.222 per share dividend for the six months ending December 2024, payable in March 2025 with a full dividend reinvestment plan available.

Ansell Limited has delivered a robust first half for FY25, reporting a near 30% increase in revenue and a remarkable 183.5% jump in net profit, driven by strong segment growth and strategic acquisition integration.

PM Capital Global Opportunities Fund Limited has announced a fully franked ordinary dividend of AUD 0.055 per security for the half-year ending December 2024, offering shareholders a Dividend Reinvestment Plan option.

Flagship Investments Limited posted a solid 9.1% gain in its investment portfolio for the half-year ending December 2024, despite a notable decline in total comprehensive income. The company declared a fully franked interim dividend of 5.1 cents per share, reflecting steady shareholder returns.

360 Capital Mortgage REIT has updated the market with the payment of a 5.2 cent per unit distribution for January 2025, marking its first under the Attribution Managed Investment Trust (AMIT) regime.

Citigroup Global Markets Australia has announced a fully franked dividend of AUD 1.10 for the REA Instalment MINI, with key dates set for early March 2025. This move aligns closely with the dividend schedule of the underlying REA Ordinary Security.

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

Spacetalk Ltd has secured a $428,853 R&D tax rebate from the Australian Taxation Office, reinforcing its commitment to innovation while reporting a 16% increase in Annual Recurring Revenue and significant cost reductions.

Atlas Arteria reveals it will face a significant temporary supplemental tax under France’s new 2025 Finance Law, impacting its APRR Group operations with payments due late next year.